Long‐term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT ‐2 study): 52‐week results from a randomized controlled trial
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long‐term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the
DEPICT
‐2 study): 52‐week results from a randomized controlled trial
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-04-21
DOI
10.1111/dom.14060
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glucose Variables in Type 1 Diabetes Studies With Dapagliflozin: Pooled Analysis of Continuous Glucose Monitoring Data From DEPICT-1 and -2
- (2019) Chantal Mathieu et al. DIABETES CARE
- Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials
- (2019) Giovanni Musso et al. BMJ-British Medical Journal
- Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
- (2019) Tadej Battelino et al. DIABETES CARE
- SGLT inhibitors in type 1 diabetes: place in therapy and a risk mitigation strategy for preventing diabetic ketoacidosis ‐ the STOP DKA Protocol
- (2019) Ronald M Goldenberg et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT‐5): 52‐week results from a randomized, open‐label, phase III clinical trial
- (2019) Eiichi Araki et al. DIABETES OBESITY & METABOLISM
- Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes
- (2019) Marc Evans et al. Diabetes Therapy
- Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study
- (2018) John B. Buse et al. DIABETES CARE
- HbA1cand Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study
- (2018) Thomas Danne et al. DIABETES CARE
- Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial
- (2018) Chantal Mathieu et al. DIABETES CARE
- SGLT inhibitor adjunct therapy in type 1 diabetes
- (2018) Rory J. McCrimmon et al. DIABETOLOGIA
- Effects of Dapagliflozin on 24-Hour Glycemic Control in Patients with Type 2 Diabetes: A Randomized Controlled Trial
- (2018) Robert R. Henry et al. Diabetes Technology & Therapeutics
- SGLT Inhibitors for Type 1 Diabetes: An Obvious Choice or Too Good to Be True?
- (2018) Matthew C. Riddle et al. DIABETES CARE
- Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study
- (2018) Paresh Dandona et al. DIABETES CARE
- Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials
- (2018) Julio Rosenstock et al. DIABETES CARE
- The Safety and Efficacy of Sodium Glucose Co-transporter 2 Inhibitors Combined with Insulin in Adults with Type 1 Diabetes: A Meta-analysis of Randomized Controlled Trials
- (2018) Kexin Li et al. Journal of Diabetes
- Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial
- (2017) Paresh Dandona et al. Lancet Diabetes & Endocrinology
- Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial
- (2016) Bo Ahrén et al. DIABETES CARE
- Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial
- (2016) Chantal Mathieu et al. DIABETES CARE
- Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association
- (2014) Jane L. Chiang et al. DIABETES CARE
- Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society
- (2013) E. R. Seaquist et al. DIABETES CARE
- Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
- (2011) D. B. Sacks et al. DIABETES CARE
- Hypoglycemia, Diabetes, and Cardiovascular Events
- (2010) C. V. Desouza et al. DIABETES CARE
- Hyperglycemic Crises in Adult Patients With Diabetes
- (2009) A. E. Kitabchi et al. DIABETES CARE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started